TGA

Caution as esketamine approved for depression

TGA recalls listed medicines over ‘unacceptable risk’

TGA software crackdown

Gilead nixes filgotinib for Australian RA patients

Dos and don’ts of promoting the COVID jab

Migraine still needs management as triptans go OTC

No happy ending with these men’s meds

Tofacitinib safety for RA in doubt
